Table 1 Patient Demographic and Clinical Characteristics: Phase I, Qualitative
Demographic and Clinical Characteristics | Total (n = 49) |
|---|---|
Age | |
Mean (SD) | 43.3 (15.43) |
Range | (19–72) |
Gender, n (%) | |
Male | 15 (30.6%) |
Female | 34 (69.4%) |
Ethnicity, n (%) | |
Hispanic or Latino | 2 (4.1%) |
Not Hispanic or Latino | 46 (93.9%) |
Missing | 1 (2.0%) |
Race,a n (%) | |
American Indian or Alaska Native | 0 (0.0%) |
Asian | 1 (2.0%) |
Black or African American | 5 (10.2%) |
Native Hawaiian or other Pacific Islander | 0 (0.0%) |
White | 40 (81.6%) |
Other | 3 (6.1%) |
SeCDAI score | |
Mean (SD) | 470.8 (262.82) |
Range | (42–1078) |
Remission (< 150) | 5 (10.2%) |
Mild (150–220) | 3 (6.1%) |
Moderate (≥ 220) | 41 (83.7%) |
Extent of disease, n (%) | |
Affecting only the colon (large intestine) | 14 (28.6%) |
Affecting only the lower small intestine (ileum and jejunum) | 6 (12.2%) |
Affecting only the upper GI tract (stomach, esophagus, and duodenum) | 0 (0.0%) |
Affecting the colon (large intestine) and lower small intestine | 22 (44.9%) |
Affecting the lower small intestine and upper GI tract | 3 (6.1%) |
Affecting the colon (large intestine), and the lower small intestine, and the upper GI tract (stomach, esophagus, and duodenum) | 4 (8.2%) |
Disease location,b n (%) | |
L1, ileal only | 4 (13%) |
L2, colonic only | 13 (43%) |
L3, ileocolonic | 12 (40%) |
L4, isolated upper disease | – |
Missing | 1 (3%) |
Disease behavior,b,c n (%) | |
B1, non-stricturing non-penetrating | 14 (47%) |
B2, stricturine | 11 (37%) |
B3, penetrating (not including abscess) | 6 (20%) |